🥼 Although adaptive resistance mechanisms re-emerge, PARP14 inhibition combined with PD-1 blockade offers a strategy to enhance treatment outcomes and overcome ICI resistance in #melanoma, reports a team from @OfficialUoM. 

 🔗| @jitcancer
#melanoma